Menlo Therapeutics Inc. Business Finance Contracts & Agreements
22 Contracts & Agreements
- Credit Agreements (5 contracts)
- Investor Rights Agreements (1)
- Purchase Agreements (5)
- Registration Rights Agreements (3)
- Share Agreements (1)
- Stock Agreements (3)
- Underwriting Agreements (2)
- Warrant Agreements (2)
- Form of Registration Rights Agreement, dated as of October 27, 2023, by and among VYNE Therapeutics Inc. and the Purchasers (Filed With SEC on October 30, 2023)
- Form of Securities Purchase Agreement, dated as of October 27, 2023, by and among VYNE Therapeutics Inc. and the Purchasers (Filed With SEC on October 30, 2023)
- Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on October 30, 2023)
- Registration Rights Agreement, dated November 11, 2022, between VYNE Therapeutics Inc. and Mutual Fund Series Trust, on behalf of Alpha (Filed With SEC on November 14, 2022)
- Securities Purchase Agreement, dated November 11, 2022, between VYNE Therapeutics Inc. and Mutual Fund Series Trust, on behalf of Alpha (Filed With SEC on November 14, 2022)
- Registration Rights Agreement, dated as of March 15, 2022, by and between the Company and Lincoln Park (Filed With SEC on March 15, 2022)
- Purchase Agreement, dated as of March 15, 2022, by and between the Company and Lincoln Park (Filed With SEC on March 15, 2022)
- Asset Purchase Agreement, dated as of January 12, 2022, by and between VYNE Therapeutics Inc. and Journey Medical Corporation (Filed With SEC on January 13, 2022)
- Form of Securities Purchase Agreement, dated January 26, 2021, among VYNE Therapeutics Inc. and the purchasers identified therein (Filed With SEC on January 28, 2021)
- Amendment No. 1 to Amended and Restated Credit Agreement and Guaranty, dated August 5, 2020, by and among Menlo Therapeutics Inc., Foamix Pharmaceuticals Ltd., Foamix... (Filed With SEC on August 6, 2020)
- Underwriting Agreement, dated June 4, 2020, among Menlo Therapeutics Inc., Cowen and Company, LLC and Piper Sandler & Co., as representatives of the several underwriters named in... (Filed With SEC on June 9, 2020)
- Menlo Therapeutics Inc. 2019 Employee Share Purchase Plan (Filed With SEC on May 11, 2020)
- Amended and Restated Security Agreement, dated as of March 9, 2020, among Foamix Pharmaceuticals Inc., Foamix Pharmaceuticals Ltd., Menlo Therapeutics Inc. and Perceptive Credit... (Filed With SEC on May 11, 2020)
- Amended and Restated Credit Agreement and Guaranty, dated as of March 9, 2020, among Foamix Pharmaceuticals Inc., Menlo Therapeutics Inc., Foamix Pharmaceuticals Ltd., the... (Filed With SEC on May 11, 2020)
- Second Amended and Restated Warrant, by and among Menlo Therapeutics Inc. and Orbimed Royalty & Credit Opportunities III, LP (Filed With SEC on May 11, 2020)
- Second Amended and Restated Warrant, by and among Menlo Therapeutics Inc. and Perceptive Credit Holdings II, LP (Filed With SEC on May 11, 2020)
- Contingent Stock Rights Agreement, dated as of March 9, 2020, by and between Menlo Therapeutics Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on March 10, 2020)
- Form of Warrant, by and among Menlo Therapeutics Inc. and certain warrant holders of Foamix Pharmaceuticals Ltd (Filed With SEC on March 10, 2020)
- 2018 Employee Stock Purchase Plan (Filed With SEC on January 12, 2018)
- Form of Common Stock Certificate (Filed With SEC on January 12, 2018)
- Form of Underwriting Agreement (Filed With SEC on January 12, 2018)
- Second Amended and Restated Investors Rights Agreement, dated June 28, 2017, by and among the Company and the investors listed therein (Filed With SEC on December 28, 2017)
